C Diff Foundation | SAP Partner

Richard Haupt, MD, MPH, discusses what is needed to ensure that a future C. diff vaccine is adequately stocked and delivered to wherever individuals show up for vaccination.

Barley Chironda, RPN, CIC, discusses current guidance for disinfection practices against C. diff.

Edmond Hooker, MD, DrPH, discusses the cost benefit of investing in launderable hospital mattress covers to prevent CDIs.

In case you missed them, we've compiled the top 5 articles from this past week.

Dr. Richard Vickers, explains how ridinilazole is unique in its spectrum of activity compared with other antibiotics that target C. diff and have been approved or are in development.

Richard Haupt, MD, MPH, discusses what would be required to adequately implement the delivery of a future C. diff vaccine.

Barley Chironda, RPN, CIC, explains what the “chain of infection” is and what is needed to break it.

Dr. Richard Vickers, explains how antibiotics used to treat C. diff also damage the microbiome.

At the 5th annual international C. diff Awareness Conference and Health Expo, Dr. Edmond Hooker discussed an underreported problem in health care facilities everywhere.

Edmond Hooker, MD, DrPH, discusses the use of a launderable mattress cover to reduce C. diff rates in hospitals.

Richard Haupt, MD, MPH, sheds light on the Clostridium difficile Vaccine Efficacy Trial (CLOVER).

Dr. Richard Vickers, explains what makes ridinilazole unique.

Richard Haupt, MD, MPH, discusses the process for developing a vaccine.

Edmond Hooker, MD, DrPH, explains how regulatory agencies are “turning a blind eye” to an important issue experienced in hospitals everywhere.

Dr. Richard Vickers explains how recurrent infection is an unmet medical need when it comes to C. difficile.

Richard Haupt, MD, MPH, discusses the different pharmaceutical companies’ efforts to develop a C. difficile vaccine.

Richard Haupt, MD, MPH, explains how Pfizer is addressing the need for a C. difficile vaccine.

Edmond Hooker, MD, DrPH, discusses how many people have fallen ill or even died due to contaminated hospital mattresses.

Dr. Richard Vickers explains how antibiotics to treat Clostridium difficile infection cause collateral damage to the gut microbiome.

Edmond Hooker, MD, DrPH, discusses the reasons behind why hospital rooms are not being disinfected properly.

Richard Haupt, MD, MPH, explains how a vaccine can serve as a primary prevention modality against C. difficile.

Many US Governors have signed a state proclamation proclaiming November 2017 as Clostridium difficile Infection Awareness Month,

Richard Haupt, MD, MPH, explains why a vaccine to help prevent C. difficile is so needed.

Edmond Hooker, MD, DrPH, explains why hospital mattresses are harder to disinfect than other harder surfaces.

Richard Haupt, MD, MPH, explains the risk factors for Clostridium difficile infection.

Paul Feuerstadt, MD, sheds light on the estimated burden of C. difficile infection in the United States.

Norman B. Javitt, MD, PhD, explains how antibiotics can impact bile acid composition and result in Clostridium difficile infection.

Barley Chironda, RPN, CIC, discusses current infection control measures taken to prevent C. difficile and the reasons why they are falling short.

Joe Sliman, MD, MPH, explains how antibiotics affect the gut microbiome.

Glenn Tillotson, PhD, FIDSA, discusses the societal value of antibiotics.